Advent of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis treatment: What consequences on Aspergillus-related diseases? Preliminary insights.
J Cyst Fibros
; 21(6): 1084-1085, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36151024
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cystic Fibrosis
Limits:
Humans
Language:
En
Journal:
J Cyst Fibros
Year:
2022
Document type:
Article